Merck's Q1 Earnings Growth Will Likely Be Led By Higher Keytruda Sales - Forbes

Merck's Q1 Earnings Growth Will Likely Be Led By Higher Keytruda Sales  Forbes

Merck (NYSE:MRK) is expected to publish its Q1 2019 results on April 30. This note details Trefis' forecasts for Merck, as well as some of the key trends we will ...